Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ricovir vs Historical Control in Chronic Hepatitis B
NCT05355467Phase 4Completed
- Sponsor
- Mylan
- Start
- Aug 2019
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Mylan. Started Aug 2019; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT05355467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05355467.